PROPESS

This brand name is authorized in Austria, Brazil, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Japan, Lithuania, Mexico, Netherlands, Romania, Turkey, United Kingdom, South Africa

Active ingredients

The drug PROPESS contains one active pharmaceutical ingredient (API):

1 Dinoprostone UNII K7Q1JQR04M - DINOPROSTONE

Read about Dinoprostone

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
G02AD02	Dinoprostone	G Genito urinary system and sex hormones → G02 Other gynecologicals → G02A Oxytocics → G02AD Prostaglandins
Discover more medicines within G02AD02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 521401401175312
Country: EE	Ravimiamet	Identifier(s): 1759080
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 62088
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 082727
Country: FR	Base de données publique des médicaments	Identifier(s): 60297517
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 104966
Country: HK	Department of Health Drug Office	Identifier(s): 41119
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 6873
Country: JP	医薬品医療機器総合機構	Identifier(s): 24997A2H1020
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1085995
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 432M96
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 50970
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W65241001
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8697621900530
Country: ZA	Health Products Regulatory Authority	Identifier(s): 33/19/0059